Efficacy of Recombinant Human Nerve Growth Factor in Stage 1 Neurotrophic Keratopathy

被引：1
|
作者：
Yavuz Saricay, Leyla [1 ,2 ]
Bayraktutar, Betul N. [1 ,2 ]
Lilley, Jonathan [3 ]
Mah, Francis S. [4 ,5 ]
Massaro-giordano, Mina [3 ,6 ]
Hamrah, Pedram [1 ,2 ,7 ]
机构：
[1] Tufts Univ, Ctr Translat Ocular Immunol, Tufts Med Ctr,Sch Med, Dept Ophthalmol, Boston, MA USA
[2] Tufts Univ, New England Eye Ctr, Tufts Med Sch,Cornea Serv, Dept Ophthalmol,Sch Med, Boston, MA USA
[3] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA USA
[4] Scripps Green Hosp, Dept Cornea, La Jolla, CA USA
[5] Scripps Green Hosp, Dept External Dis, La Jolla, CA USA
[6] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
[7] Tufts Med Ctr, 800 Washington St, Boston, MA 02111 USA
来源：
OPHTHALMOLOGY | 2022年 / 129卷 / 12期
关键词：
Cenegermin; Corneal nerves; Nerve growth factor; Neurotrophic kertopathy;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1448 / 1450
页数：3
相关论文
共 50 条
  • [1] Recombinant Human Nerve Growth Factor for Pediatric Neurotrophic Keratopathy
    Niruthisard, Duangratn
    Fung, Simon S. M.
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2022, 48 (07): : 303 - 305
  • [2] Tear proteomics reveals the molecular basis of the efficacy of human recombinant nerve growth factor treatment for Neurotrophic Keratopathy
    Damiana Pieragostino
    Manuela Lanzini
    Ilaria Cicalini
    Maria Concetta Cufaro
    Verena Damiani
    Leonardo Mastropasqua
    Vincenzo De Laurenzi
    Mario Nubile
    Paola Lanuti
    Giuseppina Bologna
    Luca Agnifili
    Piero Del Boccio
    Scientific Reports, 12
  • [3] Tear proteomics reveals the molecular basis of the efficacy of human recombinant nerve growth factor treatment for Neurotrophic Keratopathy
    Pieragostino, Damiana
    Lanzini, Manuela
    Cicalini, Ilaria
    Cufaro, Maria Concetta
    Damiani, Verena
    Mastropasqua, Leonardo
    De Laurenzi, Vincenzo
    Nubile, Mario
    Lanuti, Paola
    Bologna, Giuseppina
    Agnifili, Luca
    Del Boccio, Piero
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [4] Effect of recombinant human nerve growth factor treatment on corneal nerve regeneration in patients with neurotrophic keratopathy
    Balbuena-Pareja, Ana
    Bogen, Chloe S.
    Cox, Stephanie M.
    Hamrah, Pedram
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [5] Human recombinant nerve growth factor (Cenegermin) in a patient affected by primary congenital glaucoma with neurotrophic keratopathy
    Riva, Ivano
    Micheletti, Eleonora
    Fausto, Riccardo
    Bruttini, Carlo
    De Angelis, Giovanni
    Ceccuzzi, Roberto
    Quaranta, Luciano
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (04) : NP78 - NP81
  • [6] Cutting Edge: Topical Recombinant Nerve Growth Factor for the Treatment of Neurotrophic Keratopathy-Biologicals as a Novel Therapy for Neurotrophic Keratopathy
    Hamrah, Pedram
    Yavuz Saricay, Leyla
    Ozmen, M. Cuneyt
    CORNEA, 2022, 41 (06) : 673 - 679
  • [7] Emerging medical and surgical treatments for neurotrophic keratopathy: Review of human recombinant nerve growth factor and corneal neurotisation techniques
    Lee, Brendon W. H.
    Khan, Muhammad
    Ngo, Quan
    Tumuluri, Krishna
    Samarawickrama, Chameen
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 50 (08): : 941 - 942
  • [8] Efficacy and Tolerability of Cenegermin for Stage 1 Neurotrophic Keratopathy
    Yavuz Saricay, Leyla
    Bayraktutar, Betul
    Lilley, Jonathan
    Massaro-Giordano, Mina
    Hamrah, Pedram
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [9] Nerve Growth Factor Treatment for Neurotrophic Keratopathy in the IRIS® Registry
    Zidan, Asmaa A.
    Gilbert, Joshua B.
    Goldberg, Eric
    Ross, Connor
    Elze, Tobias
    Lorch, Alice C.
    Miller, Joan W.
    Dana, Reza
    Yin, Jia
    OPHTHALMOLOGY, 2025, 132 (03) : 368 - 370
  • [10] Topical Recombinant Human Nerve Growth Factor for Management of Refractory Epithelial Keratopathy
    Dai, Xi
    Zhu, Xi
    Karakus, Sezen
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
12345